Results 201 to 210 of about 93,071 (251)
A Curious Case of Patterned Scarring Alopecia
JEADV Clinical Practice, EarlyView.
Jeta Buch +3 more
wiley +1 more source
Functional Sneeze: A Case Report
Movement Disorders Clinical Practice, EarlyView.
Alexandra Lodge +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA, 2022
This JAMA Patient Page describes medication abortion and its risks and effectiveness.
Rebecca H, Cohen, Stephanie B, Teal
openaire +2 more sources
This JAMA Patient Page describes medication abortion and its risks and effectiveness.
Rebecca H, Cohen, Stephanie B, Teal
openaire +2 more sources
Australian Journal of General Practice, 2020
Medical abortion (using mifepristone followed by misoprostol to end an early pregnancy) is a more accessible and less invasive option than surgical termination and can be provided in primary care settings. However, few general practitioners (GPs) currently provide this service, and there remains great inequity in access to abortion across Australia ...
Danielle, Mazza +5 more
openaire +3 more sources
Medical abortion (using mifepristone followed by misoprostol to end an early pregnancy) is a more accessible and less invasive option than surgical termination and can be provided in primary care settings. However, few general practitioners (GPs) currently provide this service, and there remains great inequity in access to abortion across Australia ...
Danielle, Mazza +5 more
openaire +3 more sources
Clinical Obstetrics & Gynecology, 2009
Medical methods for pregnancy termination in early gestation offer women an alternative to surgical evacuation and have the potential to improve access globally to safe abortion. Several drug regimens are used with varying efficacy including mifepristone plus misoprostol, misoprostol alone, and methotrexate plus misoprostol.
Deborah, Bartz, Alisa, Goldberg
openaire +2 more sources
Medical methods for pregnancy termination in early gestation offer women an alternative to surgical evacuation and have the potential to improve access globally to safe abortion. Several drug regimens are used with varying efficacy including mifepristone plus misoprostol, misoprostol alone, and methotrexate plus misoprostol.
Deborah, Bartz, Alisa, Goldberg
openaire +2 more sources
Journal of Obstetrics and Gynaecology Canada, 2016
This guideline reviews the evidence relating to the provision of first-trimester medical induced abortion, including patient eligibility, counselling, and consent; evidence-based regimens; and special considerations for clinicians providing medical abortion care.Gynaecologists, family physicians, registered nurses, midwives, residents, and other ...
Dustin, Costescu +15 more
openaire +2 more sources
This guideline reviews the evidence relating to the provision of first-trimester medical induced abortion, including patient eligibility, counselling, and consent; evidence-based regimens; and special considerations for clinicians providing medical abortion care.Gynaecologists, family physicians, registered nurses, midwives, residents, and other ...
Dustin, Costescu +15 more
openaire +2 more sources
Counseling for medical abortion
American Journal of Obstetrics and Gynecology, 2000Counseling and education are correlated with women's satisfaction with all abortion care. They often assume a larger role in medical abortion because the patient is a more active participant in the abortion process. This article aims to enhance the practitioner's expertise in providing the information and care necessary for women considering early ...
openaire +2 more sources
Obstetrics & Gynecology, 2022
OBJECTIVE: To summarize the effectiveness and safety outcomes of medication abortion performed without prior pelvic examination or ultrasonogram (“no-test medication abortion”). DATA SOURCES: We searched the MEDLINE, Scopus, Web of Science, Cochrane (including ClinicalTrials.gov ...
Marit, Pearlman Shapiro +3 more
openaire +2 more sources
OBJECTIVE: To summarize the effectiveness and safety outcomes of medication abortion performed without prior pelvic examination or ultrasonogram (“no-test medication abortion”). DATA SOURCES: We searched the MEDLINE, Scopus, Web of Science, Cochrane (including ClinicalTrials.gov ...
Marit, Pearlman Shapiro +3 more
openaire +2 more sources
Journal of Midwifery & Women's Health, 2007
This article provides an overview of medication abortion in the United States 6 years after the approval of mifepristone (RU486; Mifeprex; Danco Laboratories, LLC, New York, NY) by the US Food and Drug Administration (FDA). The adoption of mifepristone is considered in the context of epidemiologic data on abortion, abortion access, and the safety of ...
openaire +2 more sources
This article provides an overview of medication abortion in the United States 6 years after the approval of mifepristone (RU486; Mifeprex; Danco Laboratories, LLC, New York, NY) by the US Food and Drug Administration (FDA). The adoption of mifepristone is considered in the context of epidemiologic data on abortion, abortion access, and the safety of ...
openaire +2 more sources
Predictors of acceptability of medication abortion
Contraception, 2007We evaluated the sociodemographic and clinical factors, including expectations, associated with satisfaction with medication abortion.Four sites enrolled 1080 subjects in a randomized trial of misoprostol 6-8 h versus misoprostol 24 h after mifepristone treatment for abortion at up to 63 days' gestation.
Stephanie B, Teal +2 more
openaire +2 more sources